Successful Deals with PwC: QIAGEN and EQT Private Equity agree on an all-cash public takeover offer

EQT Private Equity and QIAGEN have announced an agreement on a recommended voluntary all-cash public takeover offer for all outstanding QIAGEN shares at an enterprise value of around EUR 10.8 billion (USD 12.1 billion). The offer is made by a holding company indirectly controlled by the EQT XI fund, with further indirect participations held by co-investors Luxinva S.A. (a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA)) and CPP Investment Board Europe Inc. (a wholly-owned subsidiary of Canada Pension Plan Investment Board (CPP Investments)). The transaction remains subject to the offer conditions and regulatory clearances, and closing is expected in mid-2027.

We are proud that our team at PwC Switzerland was alongside EQT throughout. And we thank the EQT deal team for their trust and congratulate everyone involved on both sides. We look forward to following QIAGEN's next chapter.


The PwC team

Thank you to everyone who made it happen:

Financial Due Diligence 
  • Luca Borrelli (Partner)
  • Nicola Barusco (Director)
  • Alix Ekus (Director)
  • Donny Germosen (Senior Manager)
  • Malavika Krishnan (Senior Manager - UK)
  • Erika Meta (Senior Manager)
  • Florence Quimper-Giroux (Manager)
  • William Ndocko (Senior Associate)
  • Alain Wirth (Senior Associate)
HR & Pensions matters 
  • Kristi Leibur-Nagel (Partner)
  • Ester Lamerikx (Senior Manager)
  • David Stonebanks (Manager)
  • Joice Borel (Senior Associate)

Successful Deals with PwC

{{filterContent.facetedTitle}}

{{contentList.dataService.numberHits}} {{contentList.dataService.numberHits == 1 ? 'result' : 'results'}}
{{contentList.loadingText}}

Contact us

Luca Borrelli

Partner, Swiss Health Industries Deals Leader, Zurich, PwC Switzerland

+41 58 792 22 78

Email